Assay Details
Target Gene Details
Entrez Gene ID: | 140739 |
Gene Name: | ubiquitin conjugating enzyme E2 F (putative) |
Gene Aliases: |
NCE2 |
Location: |
Chr.2:237966945-238042782 on Build GRCh38 |
Assay Gene Location: | Within Intron 2 |
Gene Symbol | Transcript Accession | Exon Location | Assay Transcript Location | Protein ID |
---|---|---|---|---|
UBE2F | NM_001278305.1 | NP_001265234.1 | ||
NM_001278306.1 | NP_001265235.1 | |||
NM_001278307.1 | NP_001265236.1 | |||
NM_001278308.1 | NP_001265237.1 | |||
NM_080678.2 | NP_542409.1 | |||
NR_103498.1 | ||||
NR_103499.1 | ||||
NR_103500.1 | ||||
AK290063.1 | ||||
AK293334.1 | ||||
AK294107.1 | ||||
AK297502.1 | ||||
AK303094.1 | ||||
BC010549.1 | AAH10549.1 | |||
BM920749.1 | ||||
BQ959565.1 | ||||
BX421077.2 | ||||
DA140546.1 | ||||
DB118122.1 |
Target Gene Details
Entrez Gene ID: | 100533179 |
Gene Name: | UBE2F-SCLY readthrough (NMD candidate) |
Gene Aliases: |
- |
Location: |
Chr.2:237966945-238099413 on Build GRCh38 |
Assay Gene Location: | Within Intron 1 |
Gene Symbol | Transcript Accession | Exon Location | Assay Transcript Location | Protein ID |
---|---|---|---|---|
UBE2F-SCLY | NR_037904.1 |
Target Copy Number Variation Details
DGV Version: |
Release date: 2016-05-15, GRCh GRCh38 |
Target Variation |
Location | CNV Subtype |
Genes |
---|---|---|---|
nsv508205 | Chr.2:237889539 - 237970025 on Build GRCh38 | Deletion | RAMP1 UBE2F-SCLY UBE2F |
nsv1000252 | Chr.2:235899999 - 238766417 on Build GRCh38 | Loss | COL6A3 GBX2 TRAF3IP1 ASB18 PRLH COPS8 ESPNL LOC643387 HES6 LINC01107 AGAP1 RBM44 KLHL30 LOC105373991 RAB17 MLPH ILKAP RAMP1 LOC101927958 PER2 ASB1 LOC105373944 SCLY UBE2F LOC93463 MIR6811 ERFE LOC105373958 UBE2F-SCLY ACKR3 LRRFIP1 IQCA1 LOC151174 |
More Information
Additional Information:
For this assay, SNP(s) [rs115164308] are located under a primer or probe sequence. To help evaluate the possible impact of a given SNP on your experiment, please refer to the 1000 Genomes and NCBI dbSNP databases. A higher minor allele frequency in your study population represents a higher risk to assay performance.
Set Membership: |
Intragenic Intronic Non-exonic DGV Variation |